Introductory paragraph
Cell division by meiosis involves an extraordinary chromosome choreography including pairing, synapsis and crossing over between homologous chromosomes 1, 2 . The many meiosisspecific genes involved in these processes also constitute a latent toolbox of chromosome remodelling and recombination factors that may be exploited through aberrant expression in cancer 3, 4 . Here, we report that TEX12, a structural protein involved in meiotic chromosome synapsis [5] [6] [7] , is aberrantly expressed in human cancers, with high TEX12 levels correlating with poor prognosis. We find that TEX12 knock-down causes proliferative failure in multiple cancer cell lines, and confirm its role in the early stages of oncogenesis through murine cancer models. Remarkably, somatically expressed TEX12 localises to centrosomes, leading to altered centrosome number and structure, features associated with cancer development.
Further, we identify TEX12 in meiotic centrin-rich bodies, likely precursors of the mitotic centrosome, suggesting that this may represent an additional cellular function of TEX12 in meiosis that has been previously overlooked. Thus, we propose that an otherwise meiotic function of TEX12 in centrosome duplication is responsible for promoting oncogenesis and cellular proliferation in cancer, which may be targeted for novel cancer therapeutics and diagnostics.
Main text
The process of reductive cell division by meiosis is characterised by the assembly of the synaptonemal complex (SC) 1, 8 . This supramolecular protein structure binds together homologous chromosome pairs and is essential for the maturation of inter-homologue crossover recombination events, and thereby fertilty 1, 2, 8, 9 . The structural roles of the SC include chromosome remodelling through axis compaction, chromatin loop stabilisation by SYCP3 10 , and the physical tethering of homologues by an SYCP1 zipper-like lattice that is stabilised by a series of SC central element proteins 11 . The central element includes a 4:4 complex between TEX12 and SYCE2, which undergoes filament-like self-assembly into structures that are thought to enable SC growth along the entire length of meiotic chromosomes [5] [6] [7] . On the basis of their roles in chromosome structure, and their predicted functional interaction with the DNA recombination machinery, we reasoned that SC components could be detrimental to chromosomal stability if expressed outside the regulated process of meiosis, and thus could contribute to the onset and/or maintenance of cancer. In support of this, SYCP1 and central element component SYCE1 have been reported as cancer testis antigens (CTA) 12 a defined group of genes which instead of being present only in male germ cells can be abberantly re-expressed in cancer causing an immune reaction.
Furthermore, SYCP3 expression has been identified in a range of primary tumours, with a proposed role in suppressing BRCA2-mediated inter-sister recombination 13 .
To assess the role of SC proteins in human cancer, we utilised a large-scale transcriptomic analysis of ovarian cancer patient material 14 to determine SC protein expression and its correlation with disease severity. We identified the presence of multiple SC proteins in ovarian cancer patients with their expression levels correlating with survival (data not shown).
This was most striking in the case of TEX12, where its amplification correlated with a remarkably poor prognosis indicated by the absence of any long-term survivors in the TEX12amplified cohort (Fig. 1a ). We found a similar correlation of TEX12 amplification with poor survival in a number of other cancers, including glioblastoma 15 (Fig. 1b) , kidney renal clear cell carcinoma, thyroid carcinoma and uterine corpus endometrial carcinoma but not in all cases as TEX12 expression levels are unrelated to survival in prostate cancer 16 (Fig. 1c) . These findings suggest a specific pro-oncogenic functions of TEX12 in a subgroup of cancers.
We first assessed how TEX12 expression might lead to poor prognosis in human cancers. To test whether TEX12 is important for cancer cell growth, we performed siRNA knockdown of TEX12 in multiple cancer cell lines ( Fig. 1d and Supplementary Fig. 1a-b ). In the majority of cancer cell lines tested, TEX12 silencing abrogated cellular proliferation, with a failure to increase cell numbers when cultured for a period of up to seven days ( Fig. 1d ). In contrast, TEX12-negative PEO1 cancer cells and non-transformed fibroblasts showed no response to TEX12 silencing ( Fig. 1d and Supplementary Fig. 1b ). We further confirmed that this proliferative defect was not simply due to cell death ( Supplementary Fig. 1c ), establishing that TEX12 is required for cell proliferation in a subset of human cancers. We next examined the role of TEX12 in tumourigenesis using mouse models of lymphoma and hepatocellular carcinoma ( Fig. 2a-c) . In an Eµ-myc model of MYC-driven B-cell lymphoma 17 , Tex12 protein was absent in the mesenteric lymph nodes of naïve mice while it was highly expressed in the lymph nodes of all lymphoma-positive mice, as assessed by immunohistochemistry ( Fig. 2a ). Further, high lymph node expression of Tex12 was correlated with a more aggressive disease and shortened survival ( Fig. 2b ), analogous to our observations of TEX12 expression in human ovarian and glioblastoma cancers. We also detected Tex12 expression in a diethylnitrosamine (DEN)-induced mouse model of hepatocellular carcinoma 18, 19 (Fig. 2c ), indicating that these correlations are not limited to lymphoma or MYC-driven tumours. Importantly, Tex12 expression was detected as early as five weeks following DEN treatment, with peak levels observed at 40 weeks ( Fig. 2c ). Its detection at the five week-stage indicates that Tex12 is already expressed at the very early stages of oncogenesis, prior to the formation of an overt tumour. This observation raises the possibility that TEX12 is a driver of early oncogenesis and highlights its potential as an early diagnostic marker. To determine how TEX12 could contribute to cancer cell proliferation we performed immunofluorescent staining in a number of TEX12-expressing cancer cell lines using commercial TEX12 antibody ( Supplementary Fig. 2 A-C), consistently revealing the presence of TEX12 in dot-like peri-nuclear foci (Fig. 3a) . The number and location of TEX12 foci resembled that of centrosomes. Accordingly, we found that TEX12 co-localised with both centrin and pericentrin foci (Fig. 3b ,c), confirming its recruitment to centrosomes. Furthermore, FLAG-tagged TEX12 expressed in TEX12-negative COS7 cells also co-localised 7 with pericentrin in dot-like foci ( Fig. 3d ). Thus, we conclude that TEX12 is recruited to centrosomes in cancer cells.
Figure 1 TEX12 is a marker of poor prognosis in cancers and is required for cancer cell

Figure 3 TEX12 is a centrosomal protein and regulates centrosome division in cancer. (a)
Cells were stained for TEX12 visible in red with DAPI visible in blue. (b) Cells were stained for TEX12 (red), centrin (green) and nuclei were visualised in blue with DAPI. (c) Cells were stained for TEX12 (red), pericentrin (green) and nuclei were visualised in blue with DAPI. (d) COS-7 cells were transfected with TEX12 for 48h following by staining for TEX12 (red) and pericentrin (green). (e) Cancer cells were treated with non silencing control (CTR) siRNA or siTEX12 for 96h followed by centrin staining in green. Mitosis types were quantified. Interestingly, we observed that TEX12 expression is also associated with a diffuse centrosomal staining pattern indicative of rosette centrosomes, which have recently been described as a common feature of cancer cells ( Fig. 3e , f) [20] [21] [22] . Rosette centrosomes consist of mature centrosomes surrounded by a rosette of immature daughter centrioles, formed upon aberrant overduplication of centrioles, and are associated with biased chromosome capture and chromosome missegregation owing to asymmetric force of uneven number of microtubules bound to daughter centrioles at two spindle poles [22] [23] [24] . The number of cancer cells with rosette centrosomes was substantially reduced upon TEX12 silencing (Fig. 3e) , and similarly the number of rosette centrosomes positive cells was increased upon expression of TEX12 in TEX12-negative COS7 cells ( Fig. 3f ). Further, the overall number of centrosomes and pericentrin intensity were increased upon TEX12 expression ( Fig. 3g-h ). Thus, in addition to its recruitment to centrosomes in cancer cells, TEX12 actively contributes towards their amplification and structural stability.
In meiosis, TEX12 assembles into a 4:4 oligomeric complex with SYCE2 to form a structural component of the SC [5] [6] [7] . Thus, we addressed whether SYCE2, which we also found expressed in some cancer cells, is similarly recruited to centrosomes. Immunofluorescent staining of SYCE2 in cancer cells revealed a predominantly cytoplasmic pattern with no dot-like foci or overt co-localisation with pericentrin, indicating that centrosome-associated TEX12 is not in complex with SYCE2 ( Fig. 4a ). However, co-expression of SYCE2 and TEX12 in COS7 cells, a non-cancer cell line normally negative for both TEX12 and SYCE2, did lead to SYCE2 recruitment to centrosomes (Fig. 4b,c ). Thus, whilst TEX12 can be recruited to centrosomes in absence of SYCE2 ( Fig. 3f-h) , centrosome-associated TEX12 retains its SYCE2-binding ability and SYCE2 is recruited to centrosomes only when co-expressed with TEX12. We aimed to explain the ability of TEX12 to function in centrosomes independent of its binding partner SYCE2. Whilst recombinant co-expression of human SYCE2 and TEX12 was essential for the biochemical stability of SYCE2 in vitro, TEX12 was soluble and stable in absence of SYCE2 ( Fig. 4d and Supplementary Fig. 3a, b) . Analysis of the secondary structural composition, stability and oligomeric state of TEX12 by CD and SEC-MALS revealed that it is a largely α-helical homodimer, formed by a structural core of C-terminal amino-acids 49-123 ( Fig. 4e-g) , which corresponds to its SYCE2-bindinging region 7 . Further, analysis of protein size and shape by SEC-SAXS determined that the structural core adopts a largely globular conformation, with dimensions consistent with it forming a flattened four-helical structure of two helix-loop-helix chains (Fig. 4h-i and Supplementary Fig. 3c ), similar to the reported structure of another SC protein, SYCE3 25 . The specific dimeric structure adopted by TEX12 provides important validation for its SYCE2-independent centrosome function.
The pathological effect of TEX12 on centrosome function in cancer cells raises the possibility that its physiological function during meiosis might also include a centrosome function, in addition to its well-established role in chromosome synapsis. While it is generally thought that centrosomes dissipate in gametogenesis, with the loss of centrioles and formation of asymmetric microtubule organising centres, recent studies have reported the retention of centriole remnants in mature oocytes [26] [27] [28] [29] [30] . In mice it has been extensively demonstrated that oocytes contribute the centrosomes while centrosomal proteins and centrioles was reported to come from the sperm 31 . Moreover, in a published analysis of Tex12 localisation in SCdefective Sycp1 mutant spermatocytes 5 we noticed the presence of one or two prominent Tex12 immunostaining foci, and wondered if these might be centrosome-related structures.
Therefore, we immune-stained wild-type mouse spermatocytes for Tex12 and the core centriole marker Centrin (Fig 5a) . Close juxtaposition of Tex12 and Centrin was observed throughout meiotic prophase I and metaphase I (MI; Fig 5a i-viii) . In prophase I, TEX12 was localized peripheral to nuclei as an elongated or bi-lobed structure, two closely apposed foci, or two more widely separated foci. Centrin was localized immediately adjacent to these Tex12 structures, typically appearing as three or four distinct foci, indicating that centrosomes have been duplicated. During diakinesis/metaphase-I, Tex12 structures morphed into two internal toroids, each associated with two Centrin foci atop these structures (Fig 5a vi-viii) . In some metaphase-I nuclei, the two Tex12-Centrin structures appeared quite elongated and positioned on either side of the chromosome mass, with the Centrin foci on the outer, poleward faces (Fig 5a viii) .
Tex12 was also localized relative to the microtubule organizing centre (MTOC) marker, γtubulin (Fig 5b) . In prophase-I spermatocytes, the two Tex12 foci partially overlapped with bright γ-tubulin signals (Fig 5b i) . During diakinesis/metaphase-I, the two Tex12 toroids appeared to encircle two brightly staining γ-tubulin structures (Fig 5b ii) . Numerous additional γ-tubulin structures appeared at this time, many of which localized to centromere regions (that retained residual Sycp3 protein) and presumably nucleate kinetochore-associated microtubules (Fig 5b ii) . In post MI spermatocytes (that had lost residual Sycp3), two bright γtubulin-staining MTOCs remained, which were closely apposed and surrounded by interconnected Tex12 toroids (Fig 5b iii) . These structures are presumptively the precursors of MII spindles.
Finally, we confirmed that Tex12 still localized to centrosomal structures in the Sycp1 mutant (Fig 5c) , suggesting that its role at centrosomes is independent of its function in the SC. Taken together, our localization studies are consistent with TEX12 being a meiosis-specific component of the outer pericentriolar material (PCM) where it may augment or replace another PCM factor to facilitate meiotic spindle function. Our data suggest that TEX12 that does not get incorporated into SCs may be recruited to these Centrin-rich bodies, where it may perform a similar function to that observed in centrosomes of cancer cells, supporting centrosomal division. This likely represents a role of TEX12 that is favoured when it cannot participate in SC assembly, which may be analogous to the formation of chromatin-free SYCP1 polycomplexes in the absence of an SC in meiotic and somatic cells 32, 33 . We therefore propose that, in keeping with the mechanism of other meiosis-specific genes in cancer 3, 4 , the centrosomal role of TEX12 in cancer cells may represent a previously overlooked pseudomeiotic function.
Here, we report that TEX12, a structural component of the meiotic SC, is expressed in cancer at centrosomes and is indicative of poor prognosis. This dichotomy of TEX12 localisation resembles previous observations regarding Sme4/PaMe4 in fungal sexual cycle where it first takes part in the SC formation and then, after disappearing and reappearing, localises to the spindle pole body 34 . The localisation and function of TEX12 in centrosomes provides a crucial specificity that contradicts the previous rationale that the cancer transcriptome is more promiscuous and meiotic gene reexpression is a simple byproduct of cancer cell biology 35 .
Further, the identification of a similar localisation pattern in mouse meiosis indicates that the 13 role of TEX12 in centrosomes reflects a re-activation of a function that may be important for the regulation of TEX12 and SC levels, and/or for the role of centrosome-like bodies in meiosis (Fig 5d) . Additionally, it has previously been shown that centrosome amplification is sufficient to initiate tumourigenesis 36, 37 , with centrosome amplification observed in the majority of cancers 38 . Thus, the role of TEX12 in centrosome division and rosette formation provides an attractive explanation for its involvement in the early stages of oncogenesis and correlation with poor prognosis in human cancers. Furthermore, it has been recently reported that supernumerary centrosomes induce the IL-8 paracrine-signalling axis in breast cancer, leading to increased migration and invasion of cells with amplified centrosomes into the wider cellular population. This could be especially important in tumours with TEX12 amplification, such as aggressive ovarian tumours (Fig 1a) , as chromosomal TEX12 is proximal to IL-8 and hence both genes could easily be amplified together 39 . We propose that TEX12 constitutes a specific prognostic marker and a target for novel therapeutics and diagnostics in a number of human cancers. 
TEX12 is expressed in centrin rich bodies in meiosis (a) (i-vi) Mouse spermatocyte squashes stained for Centrin in blue, Sycp3 in green and Tex12 in red. (a) (vii-viii) Mouse metaphase I spermatocyte squashes stained for DAPI in blue, Centrin in green and
Materials and methods
Antibodies and plasmids -The anti-TEX12, anti-pericentrin and anti-SYCE2 antibodies were obtained from Abcam and anti-FLAG antibody was purchased from Sigma. SYCE2 and TEX12 were cloned and expressed using FLAG-pCMV-HA vector. and (C) SASI_Hs01_00169803 (Sigma). Cells were reverse transfected with siRNA using RNAiMax (Invitrogen) according to manufacturer's instructions and incubated in culture media for 96 hours prior to cell lysis and analysis. For real-time qPCR, total RNA was extracted using TRIzol (Invitrogen, 15596-026), RNA quality and yields were assessed using a NanoDrop 2000 (NanoDrop), 1μg of total RNA was reverse transcribed using SuperScript VILO (Invitrogen, 11755-050), and qPCR performed using QuantiTect SYBR Green (QIAGEN, 204143) on an ABI PRISM 7500 Sequence Detection System (Applied Biosystems). Data was tested for parametric distribution. Parametric data was analysed using appropriate t-tests or ANOVA with Bonferroni's comparison test for multiple group comparisons. Non-parametric data was analysed using Wilcoxon signed-rank test. By convention, p-values < 0.001 are marked with ***, < 0.01 with **, and < 0.05 with *.
Immunohistochemistry -Antigens were retrieved by microwaving the slides in 10mM citrate pH 6.0 for 15 minutes followed by staining the tissues. Antibodies were detected with ImmPRESS HRP IgG (Vector labs). Samples were scored blind using the histoscore methodology 40 . Briefly, percentage and intensity of staining for positive cells was estimated was used to analyse SAXS data. Data were subtracted for buffer, and then averaged for Guinier (Rg) and cross-sectional radius (Rc) analysis. P(r) distributions were generated using PRIMUS 41 and ab initio modelling was performed using DAMMIF 42 . Spermatocyte staining -Testis were dissected from freshly sacrificed mice and processed for cell squashes as previously described 43 . Briefly, seminiferous tubules were fixed in freshly prepared 2% formaldehyde containing 0.1% Triton-X for 10 mins at room temperature. Small pieces of tubules were placed on a glass slide, minced gently and then squashed under a coverslip with pressure from the blunt end of pencil. Slides were then frozen briefly in liquid nitrogen and coverslips removed. Following three washes with PBS, immunofluorescent staining was performed as described 44 Images were captured by a Hamamatsu ORCA-ER CCD camera and processed using Volocity (PerkinElmer). Supplementary Figure 1 
Supplementary Figures
